BioSpace News Archive

Novel positron emission tomography approach demonstrates the ability of Immuno-STAT based scaffolds to selectively engage tissue-resident T cells including intratumoral T cells of defined specificity CAMBRIDGE, Mass., Sept. 15, 2020 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (NASDAQ: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body, announced today the peer-reviewed publicat

Abstracts to Focus on: Results from Phase 2, Open-Label, Multicenter, 2x2 Cross-Over Trial to Assess Safety and Efficacy of MS1819 in Patients with Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis & Best Enteric Capsule for Targeted Duodenal Delivery of Non-Porcine MS1819 Lipase Enzyme NEW YORK, Sept. 15, 2020 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc (NASDAQ:AZRX) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapi

- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to participate in a fireside chat at the Morgan Stanley 18th Annual Global Healthcare Conference on Wednesday, September 16, 2020 at 2:00 pm ET. The live and archived webcast

Presentations across multiple tumour types, including six focused on hard-to-treat cancers in women, demonstrate progress in accelerating potentially transformational medicines

ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, announced it has signed an agreement with Applied StemCell, Inc., a leading provider of stem cell, animal model, antibody discovery services and reagents.

Troy Polan, acting CEO and Chief Technology Officer at Excelera, to share expertise on next-generation data analytics across a network of health system-based specialty pharmacies [15-September-2020] MINNEAPOLIS , Sept. 15, 2020 /PRNewswire/ -- Excelera ® , the company behind the Excelera Network, announced today that Troy Polan , acting CEO and Chief Technology Off

Supporting recently approved First-in-Human clinical trial at Keio University, accelerating company-sponsored clinical trials, and building a strong foundation for further growth

Pascal Biosciences Inc. and SōRSE Technology Corporation have entered into a Collaborative Research Agreement to advance Pascal’s PAS-393 into clinical testing.

cGMP Facility Builds Takeda’s Leadership Capabilities in Cell Therapy and Increases its Capacity to Supply Innovative Cell Therapies for Global Clinical Trials Five Collaborative Oncology Cell Therapy Programs Expected to be in Clinical Development by the End of FY2021 OSAKA, Japan--( BUSINESS WIRE )-- Takeda Pharmaceutical Company Limited ( TSE:4502/NYSE:TAK ) (“Takeda”) today announced the expansion of its cell therapy manufactu

Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, announced that its annual Client Congress will take place virtually this year from September 21 – 23, 2020. Client Congress builds on a decade of bringing together the nation’s most influential voices in technology and healthcare to discuss the factors shaping the U.S. marketplace with the goal of sharing the industry’s leading solutions and